SARS-CoV-2
full-length, synthetic genome

Codex DNA is making available the world's first full-length, synthetic SARS-CoV-2 genome — useful for the development of vaccines, therapeutics, and diagnostics. 

Improved

SARS-CoV-2 synthetic genome with T7 promoter

Order synthetic genome

SARS-CoV-2 synthetic genome

Order Synthetic genome

Webinar

Harnessing the power of synthetic biology to combat COVID-19

View Recording

eBook

Advancing SAR-CoV-2 research

Download

The continued SARS-CoV-2 virus mutations highlight the critical need for rapid DNA synthesis and genome writing capabilities to develop effective vaccine, therapeutic, and diagnostic solutions. Codex is uniquely positioned to support customers and collaborators with these efforts with our deep synthetic biology expertise and rapid on-demand DNA synthesis capabilities. To learn more about our full-length genome writing and modifying capabilities or to explore a strategic collaboration or partnership contact our COVID-19 response team.